MedTrace Logo

Precision Based Primary Care for Patients With Musculoskeletal Disorders

NCT07603674 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2026-05-22

No results posted yet for this study

Summary

In this research project, the researchers will implement the Start-MSK tool, which is a screening instrument to support and facilitate the work of directing the right treatment to the right patient with musculoskeletal pain to promote recovery and improve health outcomes. The screening tool aims to identify prognostic factors to stratify patients into groups with different risks for long-term pain and disability. A total of 300 patients, 18 years and older, with musculoskeletal pain who seek primary care rehabilitation and a physiotherapist will be recruited. For this project, the investigaters are in contact with 10-15 primary care units in the Stockholm, Västra Götaland, Uppsala and Skåne Regions. Patients who are recruited will receive care from a physiotherapist and with a follow-up for 6 months. The primary aim is to investigate whether Start-MSK can predict the outcome (pain, quality of life) of the treatment at 3 months, and at long-term follow-up 6 months. The investigators will also conduct interview studies using focus groups with the physiotherapists and individual interviews with included patients who are part of the study to capture their experiences of using the Start-MSK; about how the participants feel the use has affected treatment and the measures they have received. Through Start-MSK, which is a step towards precision-based treatment for musculoskeletal pain, some of the long-term pain should be preventable.

Conditions

  • Musculoskeletal Disorders (MSDs)

Interventions

OTHER

No intervention

The patients are followed over 6 month through patient reported outcome measures. No intervention other than the regular treatment that the physiotherapists give. In this project the participating physiotherapists are not instructed to treat the participating patients according to the recommended treatment level based on the risk group. The physiotherapists are instructed to use the Start MSK the first visit and to use the results in the dialogue with the patients. The investigators will follow up on what treatment that is given with a short survey at 8 weeks. This survey comprises questions on how many treatment sessions were given, and include a multiple choice question with a list of possible treatments (exercise, information, home exercise, mobilisation, manipulation, stretching, modalities etc). The physiotherapists report treatment given by checking boxes of the different treatments. This information will later be analysed in relation to risk group (low, medium and high risk).

Sponsors & Collaborators

Principal Investigators

  • Philip von Rosen, Associate professor, PhD · Karolinska Institutet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-16
Primary Completion
2026-12-30
Completion
2028-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07603674 on ClinicalTrials.gov